Our Practice
Our Team
Select Therapeutic Competencies
Company Bio
Our Values
Careers/RbD
Board of Directors
Testimonials
We're hiring!
Print Library
We're hiring!
Our Capabilities
All Capabilities
Product & Process Development
Analytical Development
Device Development
Facilities, Manufacturing, & Compliance
Quality Assurance
Project & Program Management
Regulatory Affairs
Nonclinical Development
Clinical Regulatory
Quantitative Modeling
Market Expertise
Diligence & Business Strategy
Our Advantage
The DHC Difference
Our Expertise in Practice
Straight From the Horse’s Mouth
QH Archives
White Papers
Press Releases
In the News
Publications
Regulatory Roundup
Unbridled Excellence Webinar
Contact Us
Case Study Library
Request Consultation
Back to resources
Thought Leadership Expertise
In the News
In the News
Straight From the Horse’s Mouth
QH Archives
Regulatory Roundup
White Papers
Press Releases
Publications
BPI: Planning, patient, and payer problems hurting gene therapy rollouts
BPI: Dark Horse bolsters CGT consulting outreach with BioTechLogic acquisition
Dark Horse Consulting Launches Initiative for Certification of Manufacturing Capabilities
Dark Horse Consulting Group Acquires BioTechLogic, Inc.
Dr. Kim Benton on FDA's Draft Platform Guidance for CGT
Amanda Mack and Alicja Fiedorowicz on FDA's Draft Guidance on Safety Testing of Human Allogeneic Cells
Parts 1 & 2 of DHC's Morse and Fiedorowicz on "Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Tx"
"The sweet cell of success," by DHC's Blackford and Manley
Blake Bergam and Sara Mills on FDA's Guidance on Human- and Animal-Derived Materials in CGT
Next
Join the Quarter Horse Newsletter
We’ll send you a quarterly newsletter all things DHC!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
